Atlas Trials

Pre-operative Zoledronate in Triple Negative Breast Cancer

Clinical trial NCT02347163 · TERMINATED

Trial details

NCT number
NCT02347163
Sponsor
Mario Negri Institute for Pharmacological Research
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-02-03
Primary completion
2018-06-08
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.